Abstract
Cognitive impairment is currently considered a core feature of schizophrenia (SZ) and is gaining attention as a fundamental therapeutic target. Standard treatment for SZ involves the use of antipsychotics that are successfully used to control positive symptoms and disorganized behaviour. However, it is still unclear whether they are effective on social cognition (SC) impairment. Furthermore, different medications are currently being studied to improve SC in patients with SZ. A literature search on this topic was conducted using the PubMed database. All kinds of publications (i.e., reviews, original contributions and case reports) written in English and published in the last 15 years were included. The aim of our literature review is to draw a picture of the current state of the pharmacological treatment of SC impairment in SZ.
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference141 articles.
1. Dementia praecox, oder Gruppe der Schizophrenien;Bleuler,1911
2. Allgemeine Psychopathologie;Jaspers,1913
3. Psychiatrie: Ein Lehrbuch fur Studierende und Arzte;Kraepelin,1913
4. Premorbid Intellectual Functioning and Risk of Schizophrenia and Spectrum Disorders
5. How Should DSM-V Criteria for Schizophrenia Include Cognitive Impairment?
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献